Free Trial

Evaxion A/S (EVAX) Competitors

Evaxion A/S logo
$3.05 +0.02 (+0.66%)
Closing price 03:59 PM Eastern
Extended Trading
$3.04 -0.01 (-0.49%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EVAX vs. AIMD, LEXX, BLRX, ATHA, ADAP, EDSA, IMNN, MTVA, NEUP, and PRPH

Should you be buying Evaxion A/S stock or one of its competitors? The main competitors of Evaxion A/S include Ainos (AIMD), Lexaria Bioscience (LEXX), BioLineRx (BLRX), Athira Pharma (ATHA), Adaptimmune Therapeutics (ADAP), Edesa Biotech (EDSA), Imunon (IMNN), MetaVia (MTVA), Neuphoria Therapeutics (NEUP), and ProPhase Labs (PRPH). These companies are all part of the "pharmaceutical products" industry.

Evaxion A/S vs. Its Competitors

Ainos (NASDAQ:AIMD) and Evaxion A/S (NASDAQ:EVAX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

11.0% of Evaxion A/S shares are owned by institutional investors. 10.4% of Ainos shares are owned by insiders. Comparatively, 41.6% of Evaxion A/S shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Evaxion A/S had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Evaxion A/S and 1 mentions for Ainos. Ainos' average media sentiment score of 1.68 beat Evaxion A/S's score of 0.94 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Very Positive
Evaxion A/S Positive

Evaxion A/S has higher revenue and earnings than Ainos. Evaxion A/S is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$20K927.34-$14.86M-$4.99-0.80
Evaxion A/S$3.34M1.28-$10.57M-$1.32-2.31

Ainos has a net margin of 0.00% compared to Evaxion A/S's net margin of -316.03%. Ainos' return on equity of -108.25% beat Evaxion A/S's return on equity.

Company Net Margins Return on Equity Return on Assets
AinosN/A -108.25% -56.94%
Evaxion A/S -316.03%-319.52%-63.56%

Ainos has a beta of 2.2, meaning that its share price is 120% more volatile than the S&P 500. Comparatively, Evaxion A/S has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500.

Evaxion A/S has a consensus price target of $10.00, indicating a potential upside of 227.87%. Given Evaxion A/S's stronger consensus rating and higher probable upside, analysts clearly believe Evaxion A/S is more favorable than Ainos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Evaxion A/S
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Evaxion A/S beats Ainos on 9 of the 16 factors compared between the two stocks.

Get Evaxion A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVAX vs. The Competition

MetricEvaxion A/SMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.27M$2.06B$5.76B$9.84B
Dividend YieldN/AN/A3.95%4.02%
P/E Ratio-2.3137.5831.3126.60
Price / Sales1.2813.21461.30121.37
Price / CashN/A52.2937.7659.36
Price / Book0.696.5910.026.67
Net Income-$10.57M-$63.67M$3.27B$265.59M
7 Day Performance-1.61%3.23%3.17%3.42%
1 Month Performance4.10%0.62%4.34%1.09%
1 Year Performance-79.73%28.23%44.11%23.85%

Evaxion A/S Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVAX
Evaxion A/S
2.3448 of 5 stars
$3.05
+0.7%
$10.00
+227.9%
-81.5%$4.27M$3.34M-2.3160Gap Up
AIMD
Ainos
1.0502 of 5 stars
$3.35
-3.2%
N/A+16.2%$16.12M$20K-0.6740Positive News
LEXX
Lexaria Bioscience
3.7782 of 5 stars
$0.84
+2.1%
$4.00
+378.2%
-69.1%$16.03M$460K-1.257News Coverage
BLRX
BioLineRx
3.4121 of 5 stars
$3.83
+3.2%
$26.00
+578.9%
-86.8%$15.81M$28.94M-0.4440Gap Up
ATHA
Athira Pharma
3.7498 of 5 stars
$0.39
-1.9%
$0.50
+27.3%
-87.9%$15.80MN/A-0.2540Positive News
ADAP
Adaptimmune Therapeutics
1.9691 of 5 stars
$0.07
+17.6%
$1.35
+1,831.0%
-95.2%$15.77M$65.09M-0.11490High Trading Volume
EDSA
Edesa Biotech
1.8031 of 5 stars
$2.31
+3.4%
$5.00
+116.9%
-49.0%$15.73MN/A-1.7520Gap Down
High Trading Volume
IMNN
Imunon
1.8939 of 5 stars
$6.48
+1.3%
$232.50
+3,488.0%
-65.2%$15.62M$500K-0.5030Positive News
Gap Up
MTVA
MetaVia
2.0849 of 5 stars
$0.65
+1.7%
$7.50
+1,052.8%
N/A$15.49MN/A0.008Gap Up
NEUP
Neuphoria Therapeutics
1.8946 of 5 stars
$7.79
-3.8%
$21.00
+169.6%
N/A$15.23M$10K0.00N/ANews Coverage
Analyst Forecast
Analyst Revision
PRPH
ProPhase Labs
1.3098 of 5 stars
$0.33
-4.4%
N/A-86.0%$14.51M$6.77M-0.27130Positive News

Related Companies and Tools


This page (NASDAQ:EVAX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners